Patent · US Active

Genetically modified mice expressing humanized CD40

US11497198B2 · kind B2 · utility

0Cited by

2References

4Claims

0Family size

Assignee

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. · CN

Inventors

Yuelei Shen · Beijing, CN
Chaoshe Guo · Beijing, CN
Rui Huang · Beijing, CN
Lei Zhao · Addison, US
Yanan Guo · Beijing, CN
Yang Bai · Beijing, CN
Meiling Zhang · Beijing, CN
Jiawei Yao · Beijing, CN

Key dates

Filing date	Jun 7, 2019
Grant date	Nov 15, 2022
Priority date	—
Expiry date	Jun 7, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/20
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) CD40, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.